Day: January 8, 2021

COMPASS Pathways establishes Centre of Excellence with Sheppard Prattto accelerate research and improve patient experience in mental health careLondon, UK – 8 January 2021COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, is establishing its first Centre of Excellence in collaboration with The Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore, Maryland, United States.     The Centre of Excellence will model the “clinic of the future”, showcasing the best thinking in science, therapy, technology, and design. Working as a research facility and innovation lab, it will generate evidence to shape therapy models in mental health care, train and certify therapists, conduct clinical trials including...

Chicago, IL, Jan. 08, 2021 (GLOBE NEWSWIRE) — FOMO CORP. (US OTC: ETFM) is pleased to report that the Company is now current with regard to its SEC reporting requirements as a 1934 Securities Exchange Act Company that is PCAOB audited (Public Company Accounting Oversight Board). In December 2020, management filed Forms 10-K (FY2019) and Forms 10-Q (quarters ended March 31, 2020; June 30, 2020; September 30, 2020) bringing the Company into compliance. The Company’s accountants and auditors are currently preparing the fourth quarter 2020 financials, which will include roughly six weeks of the Purge Virus, LLC (“PV”) acquisition completed October 19, 2020.Through direct sales and channel partners, Purge Virus has generated a substantial pipeline in nursing homes, hospitality, K12 schools, native tribes, and across many institutions and...

Yvan Deschamps to assume Chief Financial Officer role as François Laurin announces planned retirement from Laurentian BankMONTREAL, Jan. 08, 2021 (GLOBE NEWSWIRE) — Laurentian Bank is pleased to announce that Yvan Deschamps has been appointed to the position of Executive Vice President and Chief Financial Officer of the organization, effective April 6, 2021. Mr. Deschamps succeeds François Laurin, who informed the Bank of his desire to retire at the next Annual General Meeting. Mr. Laurin will continue to work closely with Mr. Deschamps to ensure his smooth transition into the role.“I would like to thank François Laurin for his leadership and committed service to Laurentian Bank. Earlier in 2020, François indicated to the Board of Directors and the executive team his desire to retire and agreed to extend his tenure until this year...

Yvan Deschamps remplacera François Laurin, chef de la direction financière de la Banque Laurentienne, qui a annoncé sa retraite.MONTRÉAL, 08 janv. 2021 (GLOBE NEWSWIRE) — La Banque Laurentienne est heureuse d’annoncer qu’Yvan Deschamps occupera le poste de vice-président exécutif et de chef de la direction financière à compter du 6 avril 2021. M. Deschamps succède à François Laurin, qui a indiqué qu’il souhaitait prendre sa retraite lors de la prochaine assemblée générale annuelle. M. Laurin continuera à travailler en étroite collaboration avec M. Deschamps pour assurer une transition en douceur.« Je tiens à remercier François Laurin pour son leadership et son engagement envers la Banque Laurentienne. Plus tôt en 2020, il a avisé le conseil d’administration et l’équipe de direction qu’il souhaitait prendre sa retraite, mais il a...

TORONTO, Jan. 08, 2021 (GLOBE NEWSWIRE) — Honey Badger Silver Inc. (TSXV: TUF) (“Honey Badger” or “the Company”) is pleased to announce the additional acquisition of 82 map registered cell claims, contiguous and to the west of its property holdings, within the prolific historic Thunder Bay Silver District.The acquired claims bolster the Company’s dominant land position along Thunder Bay’s Mainland Silver Belt (refer to Figure 1). The Company’s operational land portfolio now consists of 959 cell claims and 7 mining patents, covers 12 past-producing high-grade silver mines with historic production of 1.7 million ounces of silver, and encompasses approximately 20,000 hectares of ground.Figure 1: Map depicting Honey Badger’s Property, Thunder Bay Silver District: https://www.globenewswire.com/NewsRoom/AttachmentNg/f862109e-57c0-4869-9373-4ebbe94ce958About...

The global Phase 4 RESPOND study will evaluate the efficacy and safety of SPINRAZA in patients with a suboptimal clinical response to ZolgensmaClinical and real-world experience have reported that some patients previously treated with Zolgensma have also been treated with SPINRAZA1,2,3,4Biogen remains committed to exploring the potential of SPINRAZA to optimize outcomes for patients with SMACAMBRIDGE, Mass., Jan. 08, 2021 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced that the first patient has been treated in the global clinical study, RESPOND. The Phase 4 study will examine the clinical benefit and assess the safety of SPINRAZA® (nusinersen) in infants and children with spinal muscular atrophy (SMA) who still have unmet clinical needs following treatment with gene therapy Zolgensma® (onasemnogene abeparvovec). RESPOND...

On 8 January 2021 representatives of AB “Ignitis grupė” (hereinafter – Ignitis Group or the Company) participated in the meeting with Seimas Committee on Budgets and Finance and Committee on Economics, during which they intended to present information on long-term promotion of executives with shares.In order to ensure transparency and information accessibility to all interested parties, the Company is publishing, via this notice, the presentation prepared for the aforementioned meeting, which is published at the Company’s website.There are ongoing discussions in the media and at the political level about the issue of promotion of executives with shares, but the Company must note that the actual and accurate information can be found in the material event notices published at the market: the notice regarding the rules of share allocation...

2021 sausio 8 d. AB „Ignitis grupės“ (toliau – „Ignitis grupė“ arba Bendrovė) atstovai dalyvavo Seimo Biudžeto ir finansų komiteto ir Ekonomikos komiteto posėdyje, kuriame ketino pristatyti informaciją apie ilgalaikį vadovų skatinimą akcijomis.Siekiant užtikrinti skaidrumą ir informacijos prieinamumą visoms suinteresuotoms šalims, šiuo pranešimu Bendrovė skelbia minėtam posėdžiui ruoštą pristatymą, kuris patalpintas Bendrovės internetinėje svetainėje.Tuo pačiu Bendrovė pažymi, kad žiniasklaidoje ir politiniame lygmenyje vyksta diskusijos dėl vadovų ilgalaikio skatinimo, tačiau aktualią ir teisingą informaciją galite rasti Bendrovės skelbtuose esminiuose pranešimuose per biržą: 2020 m. rugsėjo 17 d. pranešimas apie Akcijų suteikimo taisykles darbuotojams ir vadovams (nuoroda), apie programą „Ignitis grupė“ paskelbė gruodžio 4 d., apie...

Information regarding the long-term promotion programme of AB “Ignitis grupė” executivesOn 8 January 2021 representatives of AB “Ignitis grupė” (hereinafter – Ignitis Group or the Company) participated in the meeting with Seimas Committee on Budgets and Finance and Committee on Economics, during which they intended to present information on long-term promotion of executives with shares.In order to ensure transparency and information accessibility to all interested parties, the Company is publishing, via this notice, the presentation prepared for the aforementioned meeting, which is published at the Company’s website.There are ongoing discussions in the media and at the political level about the issue of promotion of executives with shares, but the Company must note that the actual and accurate information can be found in the material...

25 Million Dollar Projected Project is Expected to Launch in Q1 2021Dallas, TX, Jan. 08, 2021 (GLOBE NEWSWIRE) —  via NewMediaWire — NaturalShrimp, Inc. (NSI) (OTCQB:SHMP), an aquaculture Company which has developed and patented the first commercially operational Recirculating Aquaculture System (RAS) for shrimp, announced today that it has partnered with Hydrenesis, Inc., a private technology owner and technology commercialization company that partners with leading IP holders and industry insiders to commercialize innovative technologies, to build a premier indoor shrimp production facility in northern Florida. NSI will control a 50.1% stake in the venture and will utilize its proprietary technology to oversee the shrimp-growing facilities occupied on the site. Hydrenesis will supply its hyper-antioxidant technology, along...